Novel Chimeric Antigen Receptor Signaling Domains Derived via Activity-based Directed Evolution

Invention type: Technology / Case number: #21116
License tlo.mit.edu/contact-us

Researchers

Michael Birnbaum / Taeyoon Kyung

Departments: Department of Biological Engineering
Technology Areas: Drug Discovery and Research Tools: Cell Lines & Organoids, Genomics & Proteomics / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living

  • novel chimeric antigen receptors and libraries
    United States of America | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Contact Us

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up

More Technologies

Multisensory Gamma Stimulation Promotes Glymphatic Clearance of Amyloid

#25696PH
Li-Huei Tsai / Edward Boyden / Ping-Chieh Pao / Cheng-Yi Yang / Mitchell Murdock
Biotechnology / Drug Discovery and Research Tools

A Machine Learning-guided Whole-Organ Optical Imaging Technique for Non-destructive Identification of Early Pre-Cancer Lesions and Harvesting of Viable Cells from the same for Organoid Culture

#25480
Neelkanth Bardhan / Vivek Rastogi / Angela Belcher
Artificial Intelligence (AI) and Machine Learning (ML) / Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Electronics & Photonics / Sensing & Imaging

A Multi-Pathway Reporter System that Interrogates Repair of DNA Double-Strand Breaks with Applications for Diagnosis and Therapeutic Treatment of Cancer and Neurodegenerative Diseases

#25444
Alex Kruswick / Michael Yaffe
Biotechnology / Diagnostics / Drug Discovery and Research Tools